Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
Conditions: Stage IA Uterine Sarcoma; Stage IB Uterine Sarcoma; Stage IC Uterine Sarcoma; Stage IIA Uterine Sarcoma; Stage IIB Uterine Sarcoma; Stage IIIA Uterine Sarcoma; Stage IIIB Uterine Sarcoma; Stage IIIC Uterine Sarcoma; Stage IVA Uterine Sarcoma; Stage IVB Uterine Sarcoma; Uterine CarcinosarcomaInterventions: Drug: paclitaxel; Drug: carboplatin; Radiation: external beam radiation therapy; Radiation: brachytherapy; Radiation: intensity-modulated radiation therapy; Other: laboratory biomarker analysisSponsors: Albert ...
Source: ClinicalTrials.gov - June 3, 2011 Category: Research Source Type: clinical trials
Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma; Uterine CarcinosarcomaIntervention: Drug: pazopanib hydrochlorideSponsor: National Cancer Institute (NCI)Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)Suspended - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)Suspended - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Active, not recruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials
